EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors

Enis Mert Yorulmaz iD, Kursad Donmez, Serkan Ozcan iD, Osman Kose, Sacit Nuri Gorgel, Enes Candemir, Yigit Akin iD

Diagnostics · 22.07.2025 · 15 (15) · 1840

DOI: 10.3390/diagnostics15151840 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 22.07.2025. Verfasst von Enis Mert Yorulmaz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Izmir Katip Celebi University, Izmir 35620, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Upper tract urothelial carcinoma (UTUC) is often complicated by intravesical recurrence and cancer progression following radical nephroureterectomy (RNU). Identifying reliable prognostic biomarkers remains crucial for optimizing postoperative surveillance. The goal of this study was to assess the prognostic value of the De Ritis ratio (AST/ALT) in predicting bladder recurrence and oncologic outcomes in patients with clinically localized UTUC undergoing RNU.

Methods

This retrospective study analyzed 87 patients treated with RNU between 2018 and 2025. Preoperative De Ritis ratios were calculated, and an optimal cut-off value of 1.682 was determined using ROC analysis. Recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were analyzed using the Kaplan–Meier and Cox regression methods. Logistic regression was used to identify independent predictors of bladder recurrence.

Results

A high De Ritis ratio was significantly associated with increased bladder recurrence and worse RFS and CSS, but not OS. Multivariate analysis confirmed that an elevated De Ritis ratio, current smoking, positive surgical margins, and synchronous bladder cancer were the independent predictors of bladder recurrence. The De Ritis ratio demonstrated strong discriminatory performance (AUC: 0.807), with good sensitivity and specificity for predicting recurrence.

Conclusions

The De Ritis ratio is a simple, cost-effective preoperative biomarker that may aid in identifying UTUC patients at higher risk for intravesical recurrence and cancer-specific mortality. Incorporating this ratio into clinical decision-making could enhance risk stratification and guide tailored follow-up strategies.

Schlagwörter

Stichwörter der Autor:innen

De Ritis ratiointravesical recurrencenephroureterectomyprognostic biomarkerupper tract urothelial carcinoma

Autor:innen und Institutionen

  • Department of Urology, Izmir Katip Celebi University, Izmir 35620, Turkey.
  • Department of Urology, Ataturk Research and Training Hospital, Izmir 35360, Turkey.

ORCID-Profile: Enis Mert Yorulmaz, Serkan Ozcan, Yigit Akin

Zitieren

APA

Yorulmaz, E. M., Donmez, K., Ozcan, S., Kose, O., Gorgel, S. N., Candemir, E., & Akin, Y. (2025). Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors. Diagnostics, 15(15), 1840. https://doi.org/10.3390/diagnostics15151840

Vancouver

Yorulmaz EM, Donmez K, Ozcan S, Kose O, Gorgel SN, Candemir E, et al. Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors. Diagnostics. 2025;15(15):1840. doi:10.3390/diagnostics15151840

BibTeX
@article{Yorulmaz2025,
  author = {Yorulmaz, Enis Mert and Donmez, Kursad and Ozcan, Serkan and Kose, Osman and Gorgel, Sacit Nuri and Candemir, Enes and Akin, Yigit},
  title = {Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {15},
  pages = {1840},
  doi = {10.3390/diagnostics15151840}
}
Kostenlos starten →